The Kable

The Kable

Friday Kable

๐Ÿ’‰ Valneva's Ixchiq the first approved chikungunya vaccine; Moderna, others leveraging mRNA magic; Takeda gets two FDA approvals

#469 | A breakthrough in RA research; Improved T-cell therapies; Coca-Cola safe to drink in Croatia

Ria's avatar
Vinod's avatar
Ria and Vinod
Nov 10, 2023
โˆ™ Paid

Hello, and welcome back to your favourite life sciences newsletter for the last time this week. Climate-resilient health systems are making recurring appearances in todayโ€™s edition. Our first story is anย African perspective on approaches to enhance climate-resilient and low-carbon health systems.

Developing countries like South Africa have been pushing bโ€ฆ

This post is for paid subscribers

Already a paid subscriber? Sign in
ยฉ 2026 The Kable ยท Privacy โˆ™ Terms โˆ™ Collection notice
Start your SubstackGet the app
Substack is the home for great culture